Pamicell Secures 9 Billion KRW Contract Deal
[Asia Economy Reporter Lee Seon-ae] Pharmicell announced on the 2nd that it has signed a supply contract for pharmaceutical intermediate nucleosides with Thermo Fisher Scientific. The contract amount is 8,959.2 million KRW, which corresponds to 23.73% of the sales in 2020. The contract period is until August 19, 2022.
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- Man in His 40s Who Kept Girlfriend's Body for a Year After Murder Sentenced to 30 Years in Prison Again on Appeal
- Despite Captivating the Nation for Over a Month... "Timmy" the Whale Ultimately Found Dead
- "If You Booked This Month, You Almost Lost Out... Why You Should Wait Until 'This Day' Before Paying for Flight Tickets"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
